Plasma Trimethylamine-N-Oxide Is an Independent Predictor of Long-Term Cardiovascular Mortality in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome

To investigate the association of liver metabolite trimethylamine N-oxide (TMAO) with cardiovascular disease (CV)-related and all-cause mortality in patients with acute coronary syndrome (ACS) who underwent percutaneous coronary intervention. Our prospective observational study enrolled 292 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Eyileten, Ceren, Jarosz-Popek, Joanna, Jakubik, Daniel, Gasecka, Aleksandra, Wolska, Marta, Ufnal, Marcin, Postula, Marek, Toma, Aurel, Lang, Irene M., Siller-Matula, Jolanta M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585769/
https://www.ncbi.nlm.nih.gov/pubmed/34778397
http://dx.doi.org/10.3389/fcvm.2021.728724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585769/
https://www.ncbi.nlm.nih.gov/pubmed/34778397
http://dx.doi.org/10.3389/fcvm.2021.728724

Ejemplares similares